UNC Health Medication Formulary
QR Code Add Formweb to your mobile device
Click here to submit safety event reports via SAFE
UNC Health Medication Formulary
Search results for:

donanemab

donanemab
Drug Name Form Strength ARHS Blue Ridge Caldwell Chatham Johnston Lenoir Medical Center Nash Pardee Rex Rockingham Southeastern Wayne Youth Behavioral Health
Donanemab-azbt SOLUTION, INTRAVENOUS 17.5 mg/mL (20 mL)                      

UNC Health

     System Formulary Restriction:

     Use of donanemab injection is restricted to outpatient/clinic encounters only (i.e., no inpatient use) in patients who meet the following criteria:

  • Orders must be signed by a neurology attending physician at designated clinics, including the following:
    • UNC Hospitals Neurology Clinic (Aging Brain Clinic)
    • Pardee Neurology Associates (Hendersonville or Arden locations)
    • Boone Neurological Services
    • High Country Neurology
  • Donanemab cannot be initiated in patients who:
    • Are ApoE4 homozygotes (ApoE4 status must be confirmed prior to initiation)
    • Have had a TIA/CVA in the past 6 months prior to initiation
  • A benefits investigation must be completed prior to use

Last updated: Feb. 21, 2026







This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.